BioHealth News Archive

Apply for funding under the NIAID New Innovators Award (DP2) – MIDAS

Apply for funding under the NIAID New Innovators Award (DP2) – MIDAS

The National Institute of Allergy and Infectious Diseases (NIAID) recently reissued the funding opportunity announcement (FOA) for the New Innovators Award (PAR-20-259). The first…

Read More

Sweden to have 18m vaccine doses next year: vaccine coordinator – The Local

Sweden expects to have as many as 18m doses of coronavirus vaccine by next year, enough to inoculate the entire Swedish population, according to…

Read More
University System of Maryland Rolls Out Virtual Science Labs Across All Campuses — Campus Technology

University System of Maryland Rolls Out Virtual Science Labs Across All Campuses — Campus Technology

The University System of Maryland has partnered with Labster to provide its virtual laboratory simulations across all USM institutions. The university is working to…

Read More
Emergent BioSolutions Announces FDA Approval of NARCAN® (naloxone HCl) Nasal Spray Shelf Life Extension to 36 Months NYSE:EBS

Emergent BioSolutions Announces FDA Approval of NARCAN® (naloxone HCl) Nasal Spray Shelf Life Extension to 36 Months NYSE:EBS

GAITHERSBURG, Md., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has…

Read More
Precigen Announces First Patient Dosed in Phase I/II Study of First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-associated Cancers | BioSpace

Precigen Announces First Patient Dosed in Phase I/II Study of First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-associated Cancers | BioSpace

GERMANTOWN, Md., Aug. 17, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to…

Read More
United Therapeutics Announces U.S. FDA Filing Acceptance Of Supplemental New Drug Application For Tyvaso® For Pulmonary Hypertension Associated With Interstitial Lung Disease | BioSpace

United Therapeutics Announces U.S. FDA Filing Acceptance Of Supplemental New Drug Application For Tyvaso® For Pulmonary Hypertension Associated With Interstitial Lung Disease | BioSpace

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 17, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food…

Read More

Francis Collins Relies on Science and Faith – WSJ

It takes no time for Francis Collins, the director of the National Institutes of Health, to recall the moment when he knew he wanted…

Read More
2020 Technology Showcase (NCI)

2020 Technology Showcase (NCI)

The 2020 Technology Showcase is going virtual! Reserve the afternoon of September 9th on your calendar for the 2020 Technology Showcase. The 4th annual event will…

Read More
Sign Up Now – August 26th EIR Feedback Session

Sign Up Now – August 26th EIR Feedback Session

Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your complimentary…

Read More
Register Now!  2020 BioHealth Capital Region Forum

Register Now! 2020 BioHealth Capital Region Forum

This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, Virginia Bio, Children’s National Health System, Johns Hopkins…

Read More
Kite, a Gilead Company, Looks to Expand Its Cell Therapy Maryland Operations | BioSpace

Kite, a Gilead Company, Looks to Expand Its Cell Therapy Maryland Operations | BioSpace

Maryland has become a key part of the strategy for Kite, a Gilead company, and its mission to find a cure for cancer. As…

Read More
USM Maryland Momentum Fund Invests $250,000 in $3.5M Seed Round of miRecule Inc. – USM

USM Maryland Momentum Fund Invests $250,000 in $3.5M Seed Round of miRecule Inc. – USM

Baltimore, MD. (Aug. 10, 2020) -- The University System of Maryland (USM) Momentum Fund has invested $250K in miRecule, an emerging biotech company with…

Read More
Emmes Announces its Role in Phase 1 COVID-19 Vaccine Trial | BioSpace

Emmes Announces its Role in Phase 1 COVID-19 Vaccine Trial | BioSpace

ROCKVILLE, Md., Aug. 12, 2020 /PRNewswire/ -- Emmes today announced that it provided the data and statistical analysis support for the Phase 1 clinical trial…

Read More
Emergent BioSolutions CEO on Johnson & Johnson, AstraZeneca vaccine partnerships

Emergent BioSolutions CEO on Johnson & Johnson, AstraZeneca vaccine partnerships

Emergent BioSolutions CEO Bob Kramer joined Jim Cramer on “Mad Money” to discuss the biopharmaceutical company’s role in the quest to bring a Covid-19…

Read More
Alexandria Real Estate Equities, Inc. at the Vanguard of the Life Science Ecosystem’s Rapid Scaling of COVID-19 Testing

Alexandria Real Estate Equities, Inc. at the Vanguard of the Life Science Ecosystem’s Rapid Scaling of COVID-19 Testing

PASADENA, Calif., Aug. 13, 2020 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering…

Read More